CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 116.32
+8.24 (7.62%)
Jun 19, 2026, 4:18 PM AEST
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 55.71 billion as of June 18, 2026. Its market cap has decreased by -52.87% in one year.
Market Cap
55.71B
Enterprise Value
73.39B
Revenue
23.10B
Ranking
n/a
PE Ratio
27.12
Stock Price
116.32
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 55.71B, an increase of 17,755.00%. That is a compound annual growth rate of 17.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 55.71B | -33.08% |
| Dec 31, 2025 | 83.24B | -38.95% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Telix Pharmaceuticals | 4.86B |
| Mesoblast | 2.76B |
| Neuren Pharmaceuticals | 1.61B |
| PYC Therapeutics | 1.42B |
| Clarity Pharmaceuticals | 807.80M |
| Clinuvel Pharmaceuticals | 500.75M |
| Racura Oncology | 468.08M |
| Tetratherix | 304.59M |